|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| C07K 16/40 | (2006.01) | ||
| C07K 14/47 | (2006.01) | ||
| A01K 67/027 | (2006.01) |
| (11) | Number of the document | 3067067 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16164436.4 |
| Date of filing the European patent application | 2007-03-27 | |
| (97) | Date of publication of the European application | 2016-09-14 |
| (45) | Date of publication and mention of the grant of the patent | 2020-01-08 |
| (46) | Date of publication of the claims translation | 2020-05-25 |
| (30) | Number | Date | Country code |
| 788876 P | 2006-04-03 | US | |
| 645359 | 2006-12-22 | US |
| (72) |
SCHWAEBLE, Hans-Wilhelm, GB
STOVER, Cordula Margaret, GB
TEDFORD, Clark E., US
PARENT, James B., US
FUJITA, Teizo, JP
|
| (73) |
UNIVERSITY OF LEICESTER,
University Road, Leicester, Leicestershire LE1 7RH,
GB
Omeros Corporation, 201 Elliott Avenue West, Seattle, WA 98119, US |
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Būdai, skirti būklių, susijusių su nuo MASP-2 priklausančio komplemento aktyvinimu, gydymui |
| METHODS FOR TREATING CONDITIONS ASSOCIATED WITH MASP-2 DEPENDENT COMPLEMENT ACTIVATION |
| Payment date | Validity (years) | Amount | |
| 2025-03-04 | 19 | 347.00 EUR |
| 2026-03-27 |